SCHEMBL4768522

SCHEMBL4768522

Cc1cccnc1S(=O)(=O)N(C(=O)CC(C)CCNC(=O)c1oc2ccccc2c1C)[C@H]1CCCNCC1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 9/20 0.39
RAB9A P51151 9/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
SMN1; SMN2 Q16637 4/20 0.38
KDM4E B2RXH2 2/20 0.36
GAA P10253 1/20 0.36
L3MBTL1 Q9Y468 3/20 0.35
MAPK1 P28482 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 3/20 0.34
LMNA P02545 2/20 0.34
TP53 P04637 1/20 0.34
ATM Q13315 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
HTT P42858 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
NPSR1 Q6W5P4 2/20 0.34
KCNA3 P22001 1/20 0.34
HDAC1 Q13547 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4762064 0.83 RAB9A (0.38) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL6593533 0.79 RPLP1 (0.37)
SCHEMBL4762987 0.79 RPLP1 (0.37)
SCHEMBL4765494 0.73 CTSK (0.40) NPC1RAB9ASMN1; SMN2TP53ATM
SCHEMBL6587803 0.71 RAB9A (0.40) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL6593527 0.71 RPLP1 (0.36)
SCHEMBL4763179 0.71 NPC1 (0.35) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL4767034 0.69 RPLP1 (0.34)
SCHEMBL6592307 0.69 PSEN1 (0.33)
SCHEMBL4825088 0.69 L3MBTL1 (0.39) NPC1RAB9AKMT2ASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1320370-A4 METHOD OF TREATMENT SMITHKLINE BEECHAM CORP (US) 2008-10-22 EP disclosed
EP-1320370-A1 METHOD OF TREATMENT SmithKline Beecham Corporation (US) 2003-06-25 EP disclosed
WO-2002017924-A1 METHOD OF TREATMENT SMITHKLINE BEECHAM CORPORATION (GB) 2002-03-07 WO disclosed